COURTNEY ANDERSON: Open Payments
NPI 1891309662 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 32 payments from 12 companies in 2025. Trend: 2023 $376 · 2024 $688 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $160 |
| Calliditas Therapeutics US Inc. | 3 | $91 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Ardelyx, Inc. | 2 | $34 |
| SCPHARMACEUTICALS INC. | 1 | $25 |
| Novo Nordisk Inc | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Vifor Pharma, Inc. | 1 | $19 |
Products named: Fabhalta, TARPEYO, JYNARQUE, IBSRELA, FUROSCIX, LOKELMA, Ozempic, ACTHAR.
Industry payments across NC — which companies pay providers there.
